-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HCexOp2t7nnqO43QRu8CDELoUHTWL2q1qdEDtFxKaNGvdGdaHbQ3Qa7XxG75Suzp YL/Jf2hbrL9FPwbca6fStw== 0000950123-09-011556.txt : 20090605 0000950123-09-011556.hdr.sgml : 20090605 20090604215533 ACCESSION NUMBER: 0000950123-09-011556 CONFORMED SUBMISSION TYPE: FWP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090605 DATE AS OF CHANGE: 20090604 GROUP MEMBERS: AIRPORT HOLDINGS, LLC GROUP MEMBERS: BYFIELD DRUG, INC. GROUP MEMBERS: CARE CONTINUUM, INC. GROUP MEMBERS: CFI NEW JERSEY, INC. GROUP MEMBERS: CHESAPEAKE INFUSION, INC. GROUP MEMBERS: CONNECTYOURCARE COMPANY, LLC GROUP MEMBERS: CONNECTYOURCARE, LLC GROUP MEMBERS: CURASCRIPT PBM SERVICES, INC. GROUP MEMBERS: CURASCRIPT, INC. GROUP MEMBERS: DIVERSIFIED PHARMACEUTICAL SERVICES, INC. GROUP MEMBERS: ESI CLAIMS, INC. GROUP MEMBERS: ESI ENTERPRISES, LLC GROUP MEMBERS: ESI MAIL PHARMACY SERVICE, INC. GROUP MEMBERS: ESI PARTNERSHIP GROUP MEMBERS: ESI REALTY, LLC GROUP MEMBERS: ESI RESOURCES, INC. GROUP MEMBERS: ESI-GP HOLDINGS, INC. GROUP MEMBERS: EXPRESS SCRIPTS CANADA HOLDING, CO. GROUP MEMBERS: EXPRESS SCRIPTS PHARMACEUTICAL PROCUREMENT, LLC GROUP MEMBERS: EXPRESS SCRIPTS SALES DEVELOPMENT CO. GROUP MEMBERS: EXPRESS SCRIPTS SENIOR CARE HOLDINGS, INC. GROUP MEMBERS: EXPRESS SCRIPTS SENIOR CARE, INC. GROUP MEMBERS: EXPRESS SCRIPTS SPECIALTY DISTRIBUTION SERVICES, INC. GROUP MEMBERS: EXPRESS SCRIPTS UTILIZATION MANAGEMENT CO. GROUP MEMBERS: FRECO, INC. GROUP MEMBERS: FREEDOM SERVICE COMPANY, LLC GROUP MEMBERS: HEALTHBRIDGE REIMBURSEMENT & PRODUCT SUPPORT, INC. GROUP MEMBERS: HEALTHBRIDGE, INC. GROUP MEMBERS: IBIOLOGIC, INC. GROUP MEMBERS: IVTX, INC. GROUP MEMBERS: LYNNFIELD COMPOUNDING CENTER, INC. GROUP MEMBERS: LYNNFIELD DRUG, INC. GROUP MEMBERS: MATRIX GPO, LLC GROUP MEMBERS: MOORESVILLE ON-SITE PHARMACY GROUP MEMBERS: MSC-MEDICAL SERVICES CO GROUP MEMBERS: NATIONAL PRESCRIPTION ADMINISTRATORS, INC. GROUP MEMBERS: NEXTRX SUB I, LLC GROUP MEMBERS: NEXTRX SUB II, LLC GROUP MEMBERS: NEXTRX SUB III, LLC GROUP MEMBERS: PHOENIX MARKETING GROUP, LLC GROUP MEMBERS: PRIORITY HEALTHCARE CORP GROUP MEMBERS: PRIORITY HEALTHCARE CORP WEST GROUP MEMBERS: PRIORITY HEALTHCARE DISTRIBUTION, INC. GROUP MEMBERS: PRIORITY HEALTHCARE PHARMACY, INC. GROUP MEMBERS: PRIORITYHEALTHCARE.COM, INC. GROUP MEMBERS: SINUSPHARMACY, INC. GROUP MEMBERS: SPECIALTY INFUSION PHARMACY, INC. GROUP MEMBERS: SPECTRACARE HEALTHCARE VENTURES, INC. GROUP MEMBERS: SPECTRACARE INFUSION PHARMACY, INC. GROUP MEMBERS: SPECTRACARE OF INDIANA GROUP MEMBERS: SPECTRACARE, INC. GROUP MEMBERS: SPEEDY RE-EMPLOYMENT, LLC GROUP MEMBERS: VALUE HEALTH INC / CT GROUP MEMBERS: YOURPHARMACY.COM, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: EXPRESS SCRIPTS INC CENTRAL INDEX KEY: 0000885721 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 431420563 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: FWP SEC ACT: 1934 Act SEC FILE NUMBER: 333-159654 FILM NUMBER: 09875375 BUSINESS ADDRESS: STREET 1: ONE EXPRESS WAY CITY: ST LOUIS STATE: MO ZIP: 63121 BUSINESS PHONE: 3149960900 MAIL ADDRESS: STREET 1: ONE EXPRESS WAY CITY: ST LOUIS STATE: MO ZIP: 63121 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: EXPRESS SCRIPTS INC CENTRAL INDEX KEY: 0000885721 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 431420563 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: FWP BUSINESS ADDRESS: STREET 1: ONE EXPRESS WAY CITY: ST LOUIS STATE: MO ZIP: 63121 BUSINESS PHONE: 3149960900 MAIL ADDRESS: STREET 1: ONE EXPRESS WAY CITY: ST LOUIS STATE: MO ZIP: 63121 FWP 1 c51719cfwp.htm FWP FWP
Filed Pursuant to Rule 433
Registration Statement No. 333-159654
Pricing Term Sheet
June 4, 2009
Express Scripts, Inc.

$1,000,000,000 5.250% Senior Notes due 2012
$1,000,000,000 6.250% Senior Notes due 2014
$500,000,000 7.250% Senior Notes due 2019
This term sheet to the preliminary prospectus supplement dated June 4, 2009 should be read together with the preliminary prospectus supplement before making a decision in connection with an investment in the securities. The information in this term sheet supersedes the information contained in the preliminary prospectus supplement to the extent that it is inconsistent therewith. Terms used but not defined herein have the meaning ascribed to them in the preliminary prospectus supplement.
     
Issuer:
  Express Scripts, Inc.
 
    
Ratings:
  Moody’s: Baa3 (Stable) / S&P: BBB (Stable) / Fitch: BBB (Stable)
 
    
Security Description:
  5.250% Senior Notes due 2012 (the “Notes due 2012”)
 
  6.250% Senior Notes due 2014 (the “Notes due 2014”)
 
  7.250% Senior Notes due 2019 (the “Notes due 2019”)
 
    
Aggregate Principal Amount:
  Notes due 2012: $1,000,000,000
 
  Notes due 2014: $1,000,000,000
 
  Notes due 2019: $500,000,000
 
    
Issue Price (Price to Public):
  Notes due 2012: 99.922% of Principal amount
 
  Notes due 2014: 99.574% of Principal amount
 
  Notes due 2019: 99.332% of Principal amount
 
    
Underwriting Discount:
  Notes due 2012: 0.400%
 
  Notes due 2014: 0.600%
 
  Notes due 2019: 0.650%
 
    
Maturity Date:
  Notes due 2012: June 15, 2012
 
  Notes due 2014: June 15, 2014
 
  Notes due 2019: June 15, 2019
 
Coupon:
  Notes due 2012: 5.250%
 
  Notes due 2014: 6.250%
 
  Notes due 2019: 7.250%
 
    
Weighted Average Interest Rate:
  The weighted average interest rate of the Notes due 2012, the Notes due 2014 and the Notes due 2019 is expected to be 6.1% as opposed to the assumed weighted average interest rate of 7.8% as described in the preliminary prospectus supplement.
 
    
Benchmark Treasury:
  Notes due 2012: 1.375% UST due 5/12
 
  Notes due 2014: 2.250% UST due 5/14
 
  Notes due 2019: 3.125% UST due 5/19
 
    
Benchmark Treasury Price and Yield:
  Notes due 2012: 99-18 / 1.528%
 
  Notes due 2014: 98-12 / 2.600%
 
  Notes due 2019: 95-03 / 3.720%
 
    

 

 

     
Spread to Benchmark Treasury:
  Notes due 2012: 375 bps
 
  Notes due 2014: 375 bps
 
  Notes due 2019: 362.5 bps
 
    
Yield to Maturity:
  Notes due 2012: 5.278%
 
  Notes due 2014: 6.350%
 
  Notes due 2019: 7.345%
 
    
Interest Payment Dates:
  Notes due 2012: Semi-annually in arrears
on each June 15 and December 15,
commencing on December 15, 2009
 
  Notes due 2014: Semi-annually in arrears
on each June 15 and December 15,
commencing on December 15, 2009
 
  Notes due 2019: Semi-annually in arrears
on each June 15 and December 15,
commencing on December 15, 2009
 
    
Make-Whole Redemption:
  Notes due 2012: T+50
 
  Notes due 2014: T+50
 
  Notes due 2019: T+50
 
    
Trade Date:
  June 4, 2009
 
    
Settlement Date:
  June 9, 2009 (T+3)
 
    
Legal Format:
  SEC Registered
 
    
CUSIP/ISIN:
  Notes due 2012: 302182 AC4 / US302182AC48
 
  Notes due 2014: 302182 AD2 /US302182AD21
 
  Notes due 2019: 302182 AE0 / US302182AE04
 
    
Denominations:
  $2,000 and integral multiples of $1,000 in excess thereof
 
    
Joint Book-Running Managers:
  Citigroup Global Markets Inc.
 
  Credit Suisse Securities (USA) LLC
 
  J.P. Morgan Securities Inc.
 
    
Co-Managers:
  Calyon Securities (USA) Inc.
 
  Deutsche Bank Securities Inc.
 
  Mitsubishi UFJ Securities (USA), Inc.
RBS Securities Inc.
 
  Scotia Capital (USA) Inc.
 
  SunTrust Robinson Humphrey, Inc.
 
  Wachovia Capital Markets, LLC
Concurrent Offering of Common Stock
     Concurrently with this offering we have agreed to sell 23,000,000 shares of common stock (or 26,450,000 shares if the underwriters exercise their over-allotment option in full) in an underwritten public offering (the “Concurrent Offering”). Neither the completion of the Concurrent Offering nor the completion of this offering is contingent on the completion of the other. Assuming no exercise of the underwriters’ over-allotment option with respect to the Concurrent Offering, the net proceeds of the Concurrent Offering, after deducting underwriting discounts and estimated expenses, will be approximately $1,364,417,500, based on the public offering price of $61.00 per share.

 

 

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling Citigroup Global Markets Inc. at 1-877-858-5407, Credit Suisse Securities (USA) LLC at 1-800-221-1037 or J.P. Morgan Securities Inc. at 1-212-834-4533.

 

-----END PRIVACY-ENHANCED MESSAGE-----